4.7 Article

Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: a secondary analysis of the MANTICORE trial

Amy A. Kirkham et al.

Summary: Trastuzumab impairs cardiac function and causes early myocardial inflammation, as well as detrimental changes to the cardiometabolic phenotype, which may contribute to increased cardiovascular risk in this population.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)

Review Cardiac & Cardiovascular Systems

The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review

Qinchao Wu et al.

Summary: The introduction of novel targeted drugs has significantly reduced cancer-related mortality and increased survival rates, but they also come with unexpected cardiac side effects. Understanding and exploring management measures for these side effects are crucial for maximizing the benefits of these drugs.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

Article Multidisciplinary Sciences

Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection

Kodchanan Singhanat et al.

Summary: This study demonstrates that melatonin administration at different time points during cardiac ischemia/reperfusion injury exerts similar levels of cardioprotection, and its beneficial effects on cardiac arrhythmias and mitochondrial function and dynamics are dependent on the activation of MT2 receptor.

JOURNAL OF ADVANCED RESEARCH (2021)

Article Pharmacology & Pharmacy

Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics

Apiwan Arinno et al.

Summary: Studies have shown that melatonin and metformin can reduce oxidative stress, inflammation, autophagy, apoptosis, and improve mitochondrial function to protect against Doxorubicin-induced cardiotoxicity.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Cell Biology

Silencing of lipocalin-2 improves cardiomyocyte viability under iron overload conditions via decreasing mitochondrial dysfunction and apoptosis

Sirinart Kumfu et al.

Summary: This study investigated the roles of LCN-2 and LCN-2 receptors as iron transporters in cardiomyocytes under iron overload conditions. LTCC and TTCC were found to play crucial roles in Fe2+ uptake, while DFP showed beneficial effects in both Fe2+ and Fe3+ overload conditions.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Cell Biology

Combined Administration of Metformin and Atorvastatin Attenuates Diabetic Cardiomyopathy by Inhibiting Inflammation, Apoptosis, and Oxidative Stress in Type 2 Diabetic Mice

Weikun Jia et al.

Summary: The combination therapy of metformin and atorvastatin showed superior protective effects against diabetic cardiomyopathy by inhibiting oxidative stress and inflammation, as well as reducing apoptosis of cardiomyocytes. This effect may be related to the activation of AMPK/SIRT1 signaling pathway.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Medicine, Research & Experimental

An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity

Miguel Anjos et al.

Summary: Cardiotoxicity is a major side effect of the chemotherapy drug doxorubicin, especially when combined with trastuzumab in HER2 positive cancer patients. The molecular mechanisms underlying this cardiotoxicity are complex, involving oxidative stress, impaired substrate utilization, and inhibition of topoisomerase IIB. Both drugs can damage cardiomyocytes by interfering with various signaling pathways, and other cardiac cell types may also be affected, contributing to observed clinical cardiotoxicity.

LIFE SCIENCES (2021)

Article Medicine, Research & Experimental

Acute metformin treatment provides cardioprotection via improved mitochondrial function in cardiac ischemia / reperfusion injury

Siripong Palee et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Toxicology

Mechanisms of toxic cardiomyopathy

Philippe Hantson

CLINICAL TOXICOLOGY (2019)

Article Cardiac & Cardiovascular Systems

The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity

Michele Russo et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Article Cardiac & Cardiovascular Systems

Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab

V. Quagliariello et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)

Article Endocrinology & Metabolism

Combination of low-dose testosterone and vildagliptin confers cardioprotection in castrated obese rats

Apiwan Arinno et al.

JOURNAL OF ENDOCRINOLOGY (2019)

Review Physiology

The Role of Autophagy in the Heart

Sebastiano Sciarretta et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)

Review Biochemistry & Molecular Biology

Mitochondrial dynamics: overview of molecular mechanisms

Lisa Tilokani et al.

MITOCHONDRIAL DISEASES (2018)

Article Physiology

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production

Gennaro Riccio et al.

FRONTIERS IN PHYSIOLOGY (2018)

Review Endocrinology & Metabolism

Mitochondrial Dynamics and Metabolic Regulation

Timothy Wai et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)

Article Biotechnology & Applied Microbiology

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking

Carmela Coppola et al.

ONCOTARGETS AND THERAPY (2016)

Editorial Material Oncology

MCF-7 Cells-Changing the Course of Breast Cancer Research and Care for 45 Years

Adrian V. Lee et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Editorial Material Oncology

MCF-7 Cells-Changing the Course of Breast Cancer Research and Care for 45 Years

Adrian V. Lee et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Review Physiology

MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) AND ROS-INDUCED ROS RELEASE

Dmitry B. Zorov et al.

PHYSIOLOGICAL REVIEWS (2014)

Article Medicine, Research & Experimental

Protective effect of melatonin against Adriamycin-induced cardiotoxicity

Yan Zhang et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)

Editorial Material Pharmacology & Pharmacy

Dilated cardiomyopathy following trastuzumab chemotherapy

Saurabh Karmakar et al.

INDIAN JOURNAL OF PHARMACOLOGY (2012)

Article Cell Biology

Metformin Rescues the Myocardium from Doxorubicin-Induced Energy Starvation and Mitochondrial Damage in Rats

Abdelkader E. Ashour et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)

Article Biochemistry & Molecular Biology

Metformin protects against doxorubicin-induced cardiotoxicity: Involvement of the adiponectin cardiac system

Mari C. Asensio-Lopez et al.

FREE RADICAL BIOLOGY AND MEDICINE (2011)

Article Cell Biology

The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro

Sarah J. Watkins et al.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2011)

Article Gastroenterology & Hepatology

Effects of a high-fat diet on energy metabolism and ROS production in rat liver

Guillaume Vial et al.

JOURNAL OF HEPATOLOGY (2011)

Article Endocrinology & Metabolism

Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicin- and trastuzumab-induced cardiotoxicity

Mustafa Ozturk et al.

JOURNAL OF PINEAL RESEARCH (2011)

Article Pharmacology & Pharmacy

ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat

Giuseppe Sacco et al.

VASCULAR PHARMACOLOGY (2009)

Article Pharmacology & Pharmacy

Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration

Lasse Solskov et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)

Article Oncology

Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy

Funda Meric-Bernstam et al.

CLINICAL CANCER RESEARCH (2006)

Article Cardiac & Cardiovascular Systems

Modulation by melatonin of the cardiotoxic and antitumor activities of adriamycin

CH Kim et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)

Article Cardiac & Cardiovascular Systems

Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound

P Deres et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)

Article Endocrinology & Metabolism

Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus

F Abbasi et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2004)

Review Cell Biology

Untangling the ErbB signalling network

Y Yarden et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)

Article Biochemistry & Molecular Biology

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

DH Yu et al.

ONCOGENE (2000)